Certara Inc
CERT
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.28B
Close$
$7.73
5.2% downside
Current Fair Value
5.2% downsideOvervalued by 5.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.28 Billion |
|---|---|
| Enterprise Value | $1.46 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.01 |
| Beta | 1.46 |
| Outstanding Shares | 154,356,779 |
Return
| Return on Equity | -7.08% |
|---|---|
| Return on Assets | -4.89% |
| Return on Invested Capital | 2.25% |
Valuation & Multiples
| P/E Ratio | -18.49 |
|---|---|
| PEG | -0.68 |
| Price to Sales | 4.08 |
| Price to Book Ratio | 1.36 |
| Enterprise Value to Revenue | 3.58 |
| Enterprise Value to EBIT | 50.81 |
| Enterprise Value to Net Income | -22 |
| Total Debt to Enterprise | 0.25 |
| Debt to Equity | 0.38 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 5, 2026
EPS Estimate
$0.10
Average shareholder expectationRevenue Estimate
$98.09 M
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$0.09
Average shareholder expectationRevenue Estimate
$93.20 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 2.89% |
|---|---|
| Total Calls | 200▼ 99.95% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 26.40%▼ 57.59% |
|---|---|
| Total Invested | $272.77M▼ 64.51% |
| Investors Holding | 88▼ 169.00% |
ESG Score
No data
About Certara Inc
300 employeesCertara optimizes R&D productivity, commercial value and patient outcomes through its unique portfolio of model-informed drug development, regulatory science, and market access solutions. In fact, 90+% of all novel drugs approved by the ...